Kindbody expansion layoffs: Financial struggles amid growth
The recent Kindbody expansion layoffs highlight the financial challenges faced by healthcare companies scaling rapidly to meet increased demand for fertility
Novo Nomen Closes 11% of Global Staff Amid Competition from Obesity Drug Rivals—Bloomberg Hosts Live Q&A
Novo Nordisk is planning to reduce its global workforce by approximately 11% as part of a strategic effort to regain momentum in the competitive obesity-treatment market. The cut comes amid…
BioZorb Promoted for Breast Cancer Patients Despite Regulatory and Public Complaints, Reports The Big Take
BioZorb, a medical device marketed to assist breast cancer patients, has come under scrutiny amid reports that its manufacturer failed to disclose complaints from regulators and the public. The device,…